Two of the newsletter industry's leading growth stock advisors remain bullish on the prospects of online retailer Amazon.com (NASDAQ: AMZN), based on growth in not only online retailing but new market areas ranging from the Kindle e-reader to cloud computing.

Mike Cintolo, editor of The Cabot Top Ten Report, explains, "Amazon.com recently blew away earnings expectations." Meanwhile, Alexander Green, investment director at The Oxford Club, says, "In our view, the best lies ahead for the company." Here are their reviews.

Mike Cintolo continues, "Amazon announced that its Kindle e-book reader is now its most popular selling item, both in units and in dollars. That led to a big acceleration in revenue growth (28%, the fastest in five quarters), while earnings leaped 67%.

"One of the guiding principles of our growth investing system is the concept that major trends tend to persist longer and go farther than originally expected," says Timothy Lutts.

In The Cabot Stock of the Month, he explains, "It's a principle that supports our current bullish market stance and our recommendation of Green Mountain Coffee Roasters (NASDAQ: GMCR), even though the stock is already up more than four-fold since March."

"The business, of course, is coffee, a true global mass-market product. And while Starbucks' stock peaked in 2006 (ending a 14-year run), Green Mountain Coffee Roasters is younger and far less famous.

"Green Mountain Coffee Roasters (NASDAQ: GMCR) recently reported an outstanding second quarter," notes growth stock expert Michael Cintolo in The Cabot Market Letter.

The advisor explains, "Initially after the earnings report, the stock fell following its report, supposedly because revenue growth was light. But we think focusing on that detail misses the big picture.

"First, revenue growth is still accelerating; the second quarter's rose 61% from a year ago, compared to 60%, 56% and 45% growth the prior three quarters.

For those seeking exposure to the India markets, Paul Goodwin looks to HDFC Bank (NYSE: HDB), the leading private-sector bank in India.

In his The Cabot China & Emerging Markets the advisor explains, "The company puts itself at the top of its class with its relentless revenue growth, which has averaged over 42% a year." Here's his review.

"The bank became an independent company as part of the liberalization of the Indian banking industry that began in 1994.

This post is part of a featured report on stocks in the Chinese online gaming sector.

"One lesson we learned long ago is that it often pays to recognize stocks showing unusual strength -- one such stock is NetEase (NASDAQ: NTES)," says Mike Cintolo in The Cabot Market Letter.

"In terms of stocks, NetEase is showing unusual strength. The stock started moving ahead in a powerful manner as soon as (actually a bit before) the market bottomed in March.

"In fact, NTES recently notched nine straight up weeks, all on above-average volume, breaking out of a three-year base in the process!

One month ago, we featured a special report featuring the favorite China-based stocks among financial newsletter advisors. Since then, the 14 stocks covered in the report have risen an average of more than 15%.

The performance of these stocks -- along with the overall China market -- has far exceeded the 3% gain in the S&P 500 index over the same time period. That report can be viewed here.

Despite these gains, many of the leading advisors remain bullish on China; in particular, several have recently focused on the online gaming sector in Asia. Indeed, Timothy Lutts notes that while the video game market in the U.S. is slowing, the video game market in China is expected to show 20%+ annual growth in coming year.

This post is part of a 12-article feature on the best bets for investing in China. To see all the other recommendations in this special report, click here.

"The big story behind China Life Insurance (NYSE: LFC) is still the demographic one, as the population of China urbanizing and aging," says Paul Goodwin, a specialist in Asian stocks.

In his Cabot China & Emerging Markets Report, the advisor offers a fascinating look into the company, reviewing its firm's history, it's current state and assessing its future outlook.

This post is part of a seven article report -- Food for thought: Best bets in food & beverage stocks.

"We think there's enormous potential for profit as Whole Foods Market (NASDAQ: WFMI) recovers from its deeply oversold position," says Mike Cintolo. Here's the latest from The Cabot Top Ten report.

"Whole Foods is the fourth-largest grocery store operator in the U.S., a rank it's achieved, among far older competitors, by competing not on price but on quality. In particular, Whole Foods has succeeded by satisfying shoppers' demand for healthy, earth-friendly organic foods.

This post is part of a seven article report -- Food for thought: Best bets in food & beverage stocks.

"The fast-casual restaurant category is sizzling as consumers trim their eating budgets; this trend is helping Panera Bread (NASDAQ: PNRA)," says Michael Cintolo in The Cabot Top Ten Report.

"In restaurant parlance, 'fast-casual' eateries are higher priced than fast-food chains such as McDonald's and KFC, but cheaper than casual dining restaurants such as Applebee's and Denny's.

"Illumina (NASDAQ: ILMN) makes the Genome Analyzer, which is the workhorse of the genetic medicine revolution," says growth expert Mike Cintolo in The Cabot Top Ten Report.

"The Illumina Genome Analyzer is used by genomic research centers, academic institutions, agriculture and livestock companies, pharmaceutical companies, clinical research organizations and biotechnology companies all over the world.

"In the fourth quarter of 2008, for example, the company launched the In? nium HD HumanCytoSNP-12 BeadChip, a 12 sample BeadChip priced as low as $125 per sample that enables researchers to analyze nearly 300,000 genetic markers per sample.

"Stocks are so low that the best are bound to attract bargain-hunters ... eventually," says Timothy Lutts. One such value he highlights in The Cabot Stock of the Month Report is Royal Gold (NASDAQ: RGLD).

He explains, "Royal Gold doesn't own any gold mines. It doesn't mine gold. It doesn't buy gold. And it doesn't sell gold. It simply owns the rights to royalties from a variety of precious metals producers."

"The major benefit of Royal Gold's approach to the gold business is that it involves no capital costs, no operating costs and no legal or environmental liabilities. The major drawback? Well, we haven't found it yet.

"Royal Gold is not large. It has annual revenues of just $69 million and 34 million shares outstanding. However, Royal Gold is the biggest company in the world that derives its revenues solely from precious metal royalties.

In The Cabot Benjamin Graham Value Letter -- which assesses stocks based on Graham's value investing critera, editor J. Royden Ward takes a look at Wal-Mart Stores (NYSE: WMT).

"In this month's Classic Benjamin Graham Value Model, our calculation suggests that the Dow is overvalued at 12,370 and undervalued at 8,305; as such, today the market is extremely undervalued.

"This low-risk environment means it's probably a great time to add risk by dabbling in our recommended stocks such as Wal-Mart Stores.

"How cheap is it? The recent decline in WMT shares has created an outstanding buying opportunity for investors. WMT shares now sell at only 12.3 times forward EPS with a dividend yield of 2.0%.

"Our favorite current investment idea is Netflix (NASDAQ: NFLX)," says Michael Cintolo, editor of The Cabot Top Ten Report, which each week reviews ten issues that have been showing strong price momentum.

"Netflix bolted higher on a great earnings report last week, and impressively, followed through to the upside for a few days. Bad economic times seem to mean good news for Netflix, as an evening at home with a few DVDs is way easier on the budget than even a bargain matinee at the Cineplex.

"That's the message of Netflix' boffo quarterly results that came out on January 26. Earnings walloped analysts' estimates and more than twice the predicted number of new subscribers signed up.

"Stryker (NYSE: SYK) is a bargain at 15.1x next 12-month EPS," says J. Royden Ward, editor of The Cabot Benjamin Graham Value Letter, a service which focuses on stocks that would be well-suited to the investing strategy of Ben Graham, legendary value investor and mentor to Warren Buffett.

"Stryker develops, manufactures and sells specialty surgical and medical products. Its orthopedic division makes hip, knee and other implants.

"SYK also makes a wide variety of medical products and instruments ranging from hospital beds to medical video cameras, surgical drills and saws, and instruments for implants.

Health care has long been considered a recession-resistant business. Given the current economic challenges, it's little surprise that in our survey of favorite stocks for the coming year, a number of leading advisors turned to this classic defensive sector.

In this year's Top Stock Picks from 75 advisors report, we found an intriguing group of medical-related stocks, from speculation in emerging biotech to well-established pharmaceutical firms, and from medical products makers to medical services firms focused on increasing health care efficiency and early disease detection.

Mike Cintolo, editor of The Cabot Market Letter, thinks Myriad Genetics (NASDAQ: MYGN) could be a "big winner in 2009," The company is a lead in the new field of cancer predisposition testing. For Mike's full report, read Top Stock Picks '09: Myriad Genetics.

Chuck Carlson, editor of The DRIP Investor, sees both quality and potential in Bristol-Myers Squibb (NYSE: BMY). For Chuck's full report, read Top Stock Picks '09: Bristol-Myers Squibb.